Literature DB >> 8251149

Depression, adrenal steroids, and the immune system.

A H Miller1, R L Spencer, B S McEwen, M Stein.   

Abstract

During the past decade, over 30 studies have examined the immune system in depression. While a number of investigators have reported depression-related alterations in peripheral blood immune cell number and function, many researchers have been unable to replicate these findings. The relationship between depression and the immune system has turned out to be much more complex than was initially anticipated. Factors which have complicated the interpretation of the research include the heterogeneity of depressed patients, the variability of immune assays, and the clinical relevance of these assays. In this review we conclude that alterations in the immune system do not appear to be a specific or reproducible biological correlate of depression but may occur in association with other variables which characterize depressed patients including age, sex and severity of depression. Conceptual frameworks for future research on the immune system and depression are discussed and include: (i) depression as a cofactor in the development, course and outcome of diseases involving the immune system; (ii) depression as a neuroimmunological disease; and (iii) depression as a model for studying neuroendocrine-immune interactions in humans. In terms of this third line of research, patients with depression consistently have been shown to display abnormalities in the secretion of adrenal steroids, and new data is presented which indicates that adrenal steroids may play a much more complex role in the modulation of the immune response than has been previously appreciated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251149     DOI: 10.3109/07853899309147316

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  9 in total

1.  Sick leave due to depressive disease: not a risk factor for the development of malignant lymphoma.

Authors:  Marie Nordström; Fredrik Granath; Magnus Björkholm; Anders Ekbom
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  The Effect of Depressive Symptoms on the Association Between Functional Status and Social Participation.

Authors:  Glenn V Ostir; Kenneth J Ottenbacher; Linda P Fried; Jack M Guralnik
Journal:  Soc Indic Res       Date:  2007-01

3.  Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk.

Authors:  Susan B Brown; Susan E Hankinson; Kathleen F Arcaro; Jing Qian; Katherine W Reeves
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-17       Impact factor: 4.254

4.  Depressive symptoms predict low physical performance among older Mexican Americans.

Authors:  Joshua Patino; Martin Alberto Rodriguez; Soham Al Snih
Journal:  Aging Clin Exp Res       Date:  2021-01-15       Impact factor: 4.481

5.  A meta-analysis on depression and subsequent cancer risk.

Authors:  Marjolein Ej Oerlemans; Marjan van den Akker; Agnes G Schuurman; Eliane Kellen; Frank Buntinx
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-12-03

6.  Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease.

Authors:  Mary McGrae McDermott; Philip Greenland; Jack M Guralnik; Kiang Liu; Michael H Criqui; William H Pearce; Cheeling Chan; Joseph Schneider; Leena Sharma; Lloyd M Taylor; Adnan Arseven; Maureen Quann; Lillian Celic
Journal:  J Gen Intern Med       Date:  2003-06       Impact factor: 5.128

Review 7.  Cortisol levels and the severity and outcomes of acute stroke: a systematic review.

Authors:  Amanda Jayne Barugh; Paul Gray; Susan Deborah Shenkin; Alasdair Maurice Joseph MacLullich; Gillian Elizabeth Mead
Journal:  J Neurol       Date:  2014-01-30       Impact factor: 4.849

8.  Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial.

Authors:  Joanna E Long; Mark T Drayson; Angela E Taylor; Kai M Toellner; Janet M Lord; Anna C Phillips
Journal:  Vaccine       Date:  2016-04-26       Impact factor: 3.641

9.  Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression.

Authors:  Serkan Zincir; Pelin Öztürk; Ali Emrah Bilgen; Filiz İzci; Cihad Yükselir
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-15       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.